Tirzepatide, a novel medication, is generating significant interest in the healthcare community as a potential treatment for both type 2 diabetes and reducing body fat. This unique drug works by stimulating two distinct receptors, GLP-1 and GIP, leading to better glycemic management and notable slimming in testing. While early results are promising